Hulin Chang
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Hepatology top 10%
- Liver physiology and pathology
Papers in
-
- Genomics, phytochemicals, and oxidative stress 2
-
- Liver physiology and pathology 2
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Co-authors
- Kai Qu (6 shared papers)Ting Lin (5 shared papers)Sinan Liu (7 shared papers)Jichao Wei (7 shared papers)Chang Liu (3 shared papers)Y.B. Tao (2 shared papers)Fandi Meng (6 shared papers)Zichao Huang (3 shared papers)
- Journals
- Cell Death and Disease (2 papers)Tumor Biology (2 papers)Frontiers of Medicine (1 paper)Cancer Cell International (1 paper)International Journal of Hydrogen Energy (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Hulin Chang
25 papers receiving 540 citations
Peers
Comparison fields: 5 of 87
- Cancer Research 151
- Hepatology 65
- Energy Engineering and Power Technology 14
- Molecular Biology 247
- Oncology 70
Countries citing papers authored by Hulin Chang
This map shows the geographic impact of Hulin Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hulin Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hulin Chang more than expected).
Fields of papers citing papers by Hulin Chang
This network shows the impact of papers produced by Hulin Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hulin Chang. The network helps show where Hulin Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hulin Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 91 | |
| 2 | 2016 | 65 | |
| 3 | 2014 | 38 | |
| 4 | 2020 | 35 | |
| 5 | 2016 | 33 | |
| 6 | Cisplatin induces cell cycle arrest and senescence via upregulating P53 and P21 expression in HepG2 cells. | 2013 | 32 |
| 7 | 2018 | 31 | |
| 8 | 2023 | 27 | |
| 9 | 2012 | 26 | |
| 10 | ZEB1 promotes prostate cancer proliferation and invasion through ERK1/2 signaling pathway. | 2017 | 20 |
| 11 | 2019 | 19 | |
| 12 | 2020 | 18 | |
| 13 | 2013 | 17 | |
| 14 | 2023 | 16 | |
| 15 | 2021 | 13 | |
| 16 | 2012 | 10 | |
| 17 | 2012 | 8 | |
| 18 | 2015 | 8 | |
| 19 | 2024 | 8 | |
| 20 | 2015 | 8 |
About Hulin Chang
Hulin Chang is a scholar working on Molecular Biology, Hepatology, Cancer Research, Surgery and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 544 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (2 papers), Liver physiology and pathology (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Cancer Mechanisms and Therapy (2 papers), Telomeres, Telomerase, and Senescence (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (151 citations), Hepatology (65 citations), Energy Engineering and Power Technology (14 citations), Molecular Biology (247 citations) and Oncology (70 citations). Hulin Chang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Kai Qu, Ting Lin, Sinan Liu, Jichao Wei, Chang Liu, Y.B. Tao, Fandi Meng, Zichao Huang, Hongxin Zhang and Kai Qu. Their work appears in journals such as Cell Death and Disease, Tumor Biology, Frontiers of Medicine, Cancer Cell International and International Journal of Hydrogen Energy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.